The effect of SPHK inhibition on limiting HIV-1 infection in CD4 T cells was observed irrespective of the biological sex or age of the donor (Fig. 4 and 5), with neither the variable of biological sex nor that of age reducing the effectiveness of SPHK inhibition. The gene discussed is SPHK1; the disease is HIV-1 infection.